Target intelligence / Profile preview

Salmonella Newport outer membrane porin (OMP)

Target
OMP
Molecular classification
Porin, Outer membrane protein, Beta-barrel protein, Ion channel
01

Overview

Salmonella Newport outer membrane porins are a family of pore-forming proteins, including OmpC, OmpF, and the Salmonella-specific OmpD, situated in the outer membrane of the Gram-negative bacterium Salmonella enterica serovar Newport [1][2]. These proteins form water-filled trimeric channels that allow for the passive diffusion of small hydrophilic molecules, such as sugars, ions, and amino acids, which are essential for bacterial metabolism and growth [2][4]. In clinical settings, these porins are critical because they serve as the primary gateway for many classes of antibiotics, including beta-lactams and fluoroquinolones, to enter the bacterial cell [2]. Salmonella Newport is a significant human pathogen often associated with foodborne outbreaks and multidrug resistance (MDR) [3]. Resistance is frequently achieved through the downregulation or structural modification of these porins, which limits drug uptake and renders standard treatments ineffective [2][4]. Because of their accessibility on the bacterial surface and their role in antibiotic entry, these porins are key targets for the development of potentiators that can bypass or restore membrane permeability, as well as candidates for subunit vaccines [1][4]. Sources: [1] UniProt (P0A264); [2] PubMed (PMID: 12834103); [3] CDC (Salmonella Newport Reports); [4] Journal of Bacteriology (Salmonella porin studies).

Other names
OmpCOmpFOmpDPorin proteinOuter membrane proteinSalmonella enterica serovar Newport porin
02

Mechanism of action

Facilitation of passive diffusion of hydrophilic antibiotics across the outer membrane to reach periplasmic or cytoplasmic targets.

03

Biological functions

Passive transportOsmoregulationNutrient uptakeAntibiotic permeabilityBacterial homeostasis
04

Disease associations

InfectionSalmonellosisGastroenteritisMultidrug resistance
05

Safety considerations

Rapid development of antibiotic resistance through porin lossPotential for reduced drug efficacy in low-osmolarity environmentsCross-resistance to multiple antibiotic classes
06

Interacting drugs

Ceftriaxone

6 more in the full profile.

07

Biomarkers

Porin expression levelsompC gene mutationompF gene mutationOuter membrane permeability

Beyond the preview

Go deeper on Salmonella Newport outer membrane porin (OMP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmonella Newport outer membrane porin (OMP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call